Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8775279 | Urology | 2018 | 15 Pages |
Abstract
In this contemporary cohort, clinically significant discordance was observed between the histology of metastatic liver masses and that of retroperitoneal lymph nodes. The benefit of postchemotherapy liver mass resection for patients with advanced nonseminomatous GCT is supported by favorable survival outcomes. Until more reliable predictors of postchemotherapy histology exist, complete surgical resection of all sites of residual disease should be performed whenever feasible.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Eugene J. Pietzak, Melissa Assel, Maria F. Becerra, Daniel Tennenbaum, Darren R. Feldman, Dean F. Bajorin, Robert J. Motzer, George J. Bosl, Brett S. Carver, Daniel D. Sjoberg, Joel Sheinfeld,